Skip to main content
. 2017 Jul 6;8(46):81394–81404. doi: 10.18632/oncotarget.19037

Table 2. Frequency of adverse events.

Toxicity Grade 0 1 2 3 4 5
Hematologic
Anemia 1 38 29 4 0 0
Reduced platelet count 16 38 15 3 0 0
Reduced neutrophil count 7 0 25 32 8 0
Non-hematologic
Nausea 25 33 9 5 0 0
Vomiting 47 16 7 2 0 0
Anorexia 34 29 7 2 0 0
Diarrhea 59 10 1 2 0 0
Febrile neutropenia 69 2 0 1 0 0
Abdominal pain 37 27 6 2 0 0
Asthenia 28 33 10 1 0 0
Elevated ALT 49 20 2 1 0 0
Elevated AST 44 24 3 1 0 0
T bilirubin 62 4 1 5 0 0
Pneumonitis 70 0 0 1 0 1
Edema 60 10 2 0 0 0
Myalgia 54 11 7 0 0 0
Dizziness 55 13 3 1 0 0
Headache 56 13 3 0 0 0